Close Menu
Home › Biocartis Lands €2.5M Grant From Flemish Government to Expand Manufacturing Capacity

Biocartis Lands €2.5M Grant From Flemish Government to Expand Manufacturing Capacity

Oct 18, 2016

NEW YORK (GenomeWeb) – Belgian molecular diagnostics firm Biocartis announced it has received a €2.5 million ($2.7 million) grant from the Flemish Agency for Innovation & Entrepreneurship (IWT) to expand its manufacturing capacity.

The award comes under the agency's Strategic Transformation Support program and will be used to support manufacturing of the firm's PCR-based Idylla diagnostic platform and assays. Funds will also be used to support training and education for workers at its Mechelen, Belgium facility.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jul
23
Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
25
Featured Webinar

Cell-free DNA Testing for Fetal Aneuploidy: Lessons Learned and Implications for Clinical Practice

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.

What's Popular?

In Molecular Diagnostics

  1. Eurofins Acquires Transplant Genomics

  2. FDNA, PerkinElmer Form Genetic Testing Technology Alliance

  3. Liquid Biopsy Monitoring, Surveillance Efforts Accelerate Across Cancer Types and Technologies

    Premium

  4. Menarini to Distribute PlexBio IntelliPlex MDx System

  5. Liquid Biopsy Assay From MSKCC Approved by New York State

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.